Medication Forum: SGLT2 inhibitors for type 2 diabetesThe potential role of SGLT2 inhibitors in the management of type 2 diabetes. Letter: Questioning the role of DPP-4 inhibitorsA reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. Intensive treatment may delay microvascular complications But the approach comes at the cost of increased mortality, ACCORD trial shows Long-term risks discovered following contrast nephropathy Acute kidney injury linked with mortality and heart failure risks Exposure to virulent E. coli strain sparks renal, cardiac disease Long-term followup of Walkerton victims reveals lasting impact on health Windsor hospitals launch residency program Researchers warn of dangerous antibiotic interaction Canadian EMR guru in U.S. venture Intensive BP lowering may cut stroke risk in type 2 diabetes Subgroup analysis of ACCORD trial reveals some benefit, but researcher cautions results are preliminary Yukon LPNs can do more medical tasks First Previous 65 66 67 68 69 Next Last
